Free tool
Rare disease stocks
We cover 1 company grouped under the Rare disease theme. The median market value in the group is $185.32M. Across the group, the median move over the past trading day is −1.79%. Price change over the past year runs from −33.2% to −33.2% across the middle 80 percent of the group, with a median of −33.2%.
Other lists in this group
SaaSAI applicationsCybersecuritySemiconductor designSemiconductor equipmentFintech softwarePayment processingEcommerce marketplacesStreaming mediaGaming softwareOncologyRare diseaseMedical devicesCell therapyDiagnosticsRegional banksAsset managementGold miningCryptocurrency and digital assetsSpecialty chemicalsAll stocks
Table
1 company of 268 matches these filters.Clear filters
| Ticker | Company | Market cap (USD) | Size | 1Y return | Next report |
|---|---|---|---|---|---|
| 0AB6.L | Hyloris Pharmaceuticals SA | $185.32M | Small cap | −33.23% | Sep 24, 2026 |
Covers ~22,000 companies across the US, Europe and Asia-Pacific (ex mainland China, Hong Kong and India), refreshed nightly. Every listed stock opens as a full analysis for $9.90.